Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry
Virginia Abello Polo, Claudia Sossa, Carla Boquimpani, Luis Antonio Salazar, Isabel Munevar, Rigoberto Gómez, Diana Marcela Cuervo, Carlos Varón Jaimes, Jheremy Reyes, Henry Idrobo, Paola Omaña, Jorge Daza, Julian Eduardo Pedraza Morales, Claudia Agudelo López, Guillermo E. Quintero-Vega, Mario Correa Correa, Juan Manuel Herrera, William Armando Mantilla, Juan Carlos Serrano, Carmen RosalesKenny Mauricio Gálvez Cárdenas, Carlos Bermúdez, Domingo Saavedra Ramírez, Mauricio Alzate, José Fernando Lobatón Ramírez
Research output: Articles / Notes › Scientific Article › peer-review
Fingerprint
Dive into the research topics of 'Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry'. Together they form a unique fingerprint.